Sign in
4

Changes in Ownership

Prime Medicine, Inc. Filed Acc 0001894562-25-000024

Options or other derivatives

  • Director acquired 800,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Marrazzo Jeffrey D Director 2025-05-19 Grant or award · Stock Option (right to buy) +800,000 800,000 D
Loading xslF345X05/wk-form4_1747698326.xml…